ICCS Debuts Best Practice Guidance Series Focus on Skin Sensitization Without Animal Testing

ICCS Debuts Best Practice Guidance Series Focus on Skin Sensitization Without Animal Testing

NEW YORK--(BUSINESS WIRE)--Jul 22, 2025-

FDA Moving to Nonanimal Testing Methodologies in Preclinical Research

The plan first addresses monoclonal antibodies but could eventually be applied to all compounds seeking FDA approval.

FDA Announces Plan to Phase Out Animal Testing. Will That Work? - 3 Quarks Daily

Donald Ingber in The Scientist: In April of this year, the Food and Drug Administration (FDA) announced a new roadmap that aims to replace animal testing in the development of new drugs with more human-relevant methods. The goal is to improve drug safety, accelerate the evaluation process, shorten drug development timelines, reduce costs, and spare animal lives. The FDA aims to make animal testing the exception rather than the norm within three …